Hospital
Kaplan General Hospital, INC.
Kaplan General Hospital, INC. was paid $3.98M by Medicaid between Jan 2018 and Dec 2024, across 59 billing codes. Its largest line is 99283, emergency room visit (moderate) — 39% of everything it billed.
33Billing provider infoKAPLAN GENERAL HOSPITAL, INC.
KAPLAN, LA 70548
KAPLAN, LA 70548
33aNPI1245617562assigned 05/06/2015
33bProvider typeCritical Access Hospital
28Total paid$3.98M
24GClaims66,553
24DCodes billed59
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Louisiana
Rank by total paid#18 of 40
Median peer was paid$3.19M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,504 | $363K | |
| 2019 | 9,057 | $470K | |
| 2020 | 7,485 | $312K | |
| 2021 | 13,196 | $670K | |
| 2022 | 11,976 | $774K | |
| 2023 | 10,772 | $917K | |
| 2024incomplete | 6,563 | $477K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 39% | 8,898 | 8,386 | $1.56M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 32% | 5,372 | 4,945 | $1.26M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.3% | 1,378 | 1,241 | $370K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.6% | 1,730 | 1,517 | $63K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.4% | 30 | 27 | $56K |
| 80053 | Comprehensive metabolic panel | 1.3% | 7,527 | 6,716 | $53K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.3% | 467 | 442 | $52K |
| J3490 | Unclassified drugs | 1.1% | 2,983 | 1,673 | $43K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,093 | 1,006 | $38K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 464 | 447 | $36K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 239 | 217 | $36K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 299 | 273 | $34K |
47 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,436 | $34K |
| 80061 | Lipid panel | <1% | 2,873 | $32K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 815 | $31K |
| 71045 | Radiologic examination, chest; single view | <1% | 352 | $30K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 800 | $26K |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,506 | $25K |
| 80050 | General health panel | <1% | 582 | $24K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 34 | $21K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 400 | $20K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 112 | $15K |
| 0240U | <1% | 128 | $14K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 294 | $13K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 227 | $10K |
| 94664 | <1% | 434 | $10K | |
| 81001 | <1% | 4,319 | $9K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 392 | $8K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 312 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 762 | $6K |
| 86803 | <1% | 509 | $6K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 561 | $6K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 194 | $6K |
| 81025 | <1% | 669 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 56 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 292 | $4K |
| 87400 | <1% | 327 | $4K | |
| 84484 | <1% | 487 | $3K | |
| 82553 | <1% | 346 | $2K | |
| 83880 | <1% | 98 | $2K | |
| 87449 | <1% | 146 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 145 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 111 | $1K |
| 82550 | <1% | 384 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 16 | $737.67 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 18 | $649.04 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 29 | $646.77 |
| A9150 | Non-prescription drugs | <1% | 63 | $547.84 |
| 87081 | <1% | 72 | $513.38 | |
| 87088 | <1% | 71 | $382.05 | |
| 84439 | <1% | 45 | $337.68 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 36 | $236.94 |
| J2704 | Injection, propofol, 10 mg | <1% | 185 | $199.85 |
| 83735 | <1% | 36 | $107.20 | |
| 81003 | <1% | 60 | $100.49 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 205 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 31 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 74 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCALLECOD, DAVID (PRESIDENT, CEO)
Parent organizationLAFAYETTE GENERAL HEALTH SYSTEM, INC.
| Provider | Location | Paid |
|---|---|---|
| University Hospital & Clinics, INC. | Lafayette, LA | $60.90M |
| ST Martin Hospital, INC. | Breaux Bridge, LA | $12.79M |
| Acadia General Hospital, INC. | Crowley, LA | $8.42M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.